Association of MTHFR Polymorphisms with H-Type Hypertension: A Systemic Review and Network Meta-Analysis of Diagnostic Test Accuracy
- PMID: 35360528
- PMCID: PMC8964216
- DOI: 10.1155/2022/2861444
Association of MTHFR Polymorphisms with H-Type Hypertension: A Systemic Review and Network Meta-Analysis of Diagnostic Test Accuracy
Abstract
Purpose: An association between MTHFR polymorphisms and H-type hypertension (H-HTN) has been investigated by epidemiological studies, but results have been inconsistent. Thus, a systematic assessment of the association was performed based on a literature review and pooled analysis, to provide stronger evidence on the effects of single nucleotide polymorphisms on H-HTN risk.
Methods: Three investigators independently retrieved relevant studies in PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database, and China Biomedical Literature Database (CBM). A fixed or random effects model was selected to calculate pooled odds ratio (OR) and 95% confidence intervals (CIs). A network meta-analysis of diagnostic test and Thakkinstian's algorithm were used to select the most appropriate genetic model, along with false-positive report probability (FPRP) for noteworthy associations. All data were processed using Stata 15.0 and Meta-Disc.
Results: A total of 14 studies involving 1759 cases and 1581 controls for MTHFR were included in our meta-analysis. In a direct meta-analysis, we found that MTHFR C667T rs1801133 significantly increased the risk of H-HTN susceptibility except for an overdominant model. However, MTHFR A1298C rs1801131 polymorphism had no significant correlation with H-HTN risk. Besides, MTHFR C667T rs1801133 is a potential diagnostic biomarker for estimating H-HTN risk. The results indicated that the dominant model was an optimal diagnosis model for excluding diseases, which could reduce a missed diagnosis rate and further improve the accuracy of disease diagnosis.
Conclusion: The present result suggests that MTHFR C667T rs1801133 polymorphism is associated with H-HTN risk and may act as a promising predictive biomarker for H-HTN risk. However, further well-designed studies are warranted to confirm these results.
Copyright © 2022 Yixuan Kong et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Association Between MTHFR Polymorphisms and the Risk of Essential Hypertension: An Updated Meta-analysis.Front Genet. 2021 Nov 26;12:698590. doi: 10.3389/fgene.2021.698590. eCollection 2021. Front Genet. 2021. PMID: 34899823 Free PMC article. Review.
-
MTHFR C677T, A1298C and MS A2756G Gene Polymorphisms and Male Infertility Risk in a Chinese Population: A Meta-Analysis.PLoS One. 2017 Jan 12;12(1):e0169789. doi: 10.1371/journal.pone.0169789. eCollection 2017. PLoS One. 2017. PMID: 28081209 Free PMC article.
-
Associations of methylenetetrahydrofolate reductase gene (MTHFR) rs1801131 and rs1801133 polymorphisms with susceptibility to vitiligo: A meta-analysis.J Cosmet Dermatol. 2021 Jul;20(7):2359-2368. doi: 10.1111/jocd.13857. Epub 2020 Dec 3. J Cosmet Dermatol. 2021. PMID: 33219596
-
MTHFR genetic polymorphisms may contribute to the risk of chronic myelogenous leukemia in adults: a meta-analysis of 12 genetic association studies.Tumour Biol. 2014 May;35(5):4233-45. doi: 10.1007/s13277-013-1554-9. Epub 2013 Dec 31. Tumour Biol. 2014. PMID: 24379141
-
Association of MTHFR C677T and A1298C Polymorphisms with Glaucoma Risk: a Systematic Review Meta-Analysis based 42 Case-Control Studies.Rom J Ophthalmol. 2019 Apr-Jun;63(2):107-118. Rom J Ophthalmol. 2019. PMID: 31334388 Free PMC article.
Cited by
-
Analysis of the relative risk factors for H-type hypertension and its correlation with the MTHFR C677T genotype in a health checkup population in Urumqi, China-a cross-sectional study.BMC Cardiovasc Disord. 2025 Jul 3;25(1):455. doi: 10.1186/s12872-025-04926-y. BMC Cardiovasc Disord. 2025. PMID: 40610895 Free PMC article.
-
Prevalence and clinical correlates of hyperhomocysteinemia in Chinese urban population with hypertension.Front Endocrinol (Lausanne). 2024 Feb 20;15:1369997. doi: 10.3389/fendo.2024.1369997. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38444590 Free PMC article.
References
-
- Wang W., Ji P., Wang Y., et al. Prevalence of hyperhomocysteinemia and its associated factors in patients with primary hypertension in Chinese urban communities: a cross-sectional study from Nanjing. Clinical and Experimental Hypertension . 2018;40(5):495–500. doi: 10.1080/10641963.2017.1403621. - DOI - PubMed
-
- Hu D. Y., Xu X. P. [Prevention of stroke relies on valid control H type hypertension] Zhonghua nei ke za zhi. Dec . 2008;47(12):976–977. - PubMed
Publication types
LinkOut - more resources
Full Text Sources